We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,113 hedge funds and large institutions have $48.7B invested in Thermo Fisher Scientific in 2016 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 388 increasing their positions, 434 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 55

7% more funds holding

Funds holding: 1,0441,113 (+69)

1.33% less ownership

Funds ownership: 88.67%87.34% (-1.3%)

11% less repeat investments, than reductions

Existing positions increased: 388 | Existing positions reduced: 434

12% less capital invested

Capital invested by funds: $55.2B → $48.7B (-$6.44B)

35% less funds holding in top 10

Funds holding in top 10: 9360 (-33)

46% less call options, than puts

Call options by funds: $123M | Put options by funds: $228M

Holders
1,113
Holders Change
+69
Holders Change %
+6.61%
% of All Funds
27.82%
Holding in Top 10
60
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-35.48%
% of All Funds
1.5%
New
141
Increased
388
Reduced
434
Closed
55
Calls
$123M
Puts
$228M
Net Calls
-$105M
Net Calls Change
-$130M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
501
Mitchell Capital Management
Kansas
$3.55M -$1.63M -11,072 -31%
DAM
502
Deltec Asset Management
New York
$3.54M +$3.11M +21,065 +527%
BPIM
503
Brant Point Investment Management
New York
$3.53M -$158K -1,075 -4%
KFC
504
Klingenstein Fields & Co
New York
$3.5M -$391K -2,650 -10%
LSERS
505
Louisiana State Employees Retirement System
Louisiana
$3.5M -$44.2K -300 -1%
WCA
506
Westover Capital Advisors
Delaware
$3.5M +$328K +2,223 +10%
1SB
507
1ST Source Bank
Indiana
$3.47M -$8.85K -60 -0.2%
RW
508
Rand Wealth
Maryland
$3.47M +$20.6K +140 +0.6%
ECM
509
ETrade Capital Management
Virginia
$3.45M -$312K -2,115 -8%
SRC
510
Stone Run Capital
New York
$3.42M +$14.7K +100 +0.4%
IAM
511
Integre Asset Management
New York
$3.4M -$561K -3,804 -14%
NB
512
Norinchukin Bank
Japan
$3.38M +$421K +2,856 +14%
BUB
513
BBVA USA Bancshares
Texas
$3.38M +$194K +1,315 +6%
CBB
514
Citizens Business Bank
California
$3.36M -$55K -373 -2%
NEI
515
Northwest & Ethical Investments
Ontario, Canada
$3.35M +$156K +1,058 +5%
BHWM
516
Bar Harbor Wealth Management
New Hampshire
$3.35M +$103K +699 +3%
CIM
517
Calvert Investment Management
Maryland
$3.34M -$326K -2,212 -9%
GBA
518
Garrison Bradford & Associates
New York
$3.34M +$147 +1 +0%
RCM
519
Riverhead Capital Management
Delaware
$3.33M +$383K +2,600 +12%
CIG
520
Consolidated Investment Group
Colorado
$3.32M
SLI
521
Sumitomo Life Insurance
Japan
$3.31M +$90.2K +612 +3%
CA
522
Cullinan Associates
Kentucky
$3.23M +$162K +1,100 +5%
RIM
523
Reliant Investment Management
Tennessee
$3.22M -$3.26M -22,085 -49%
Nomura Holdings
524
Nomura Holdings
Japan
$3.2M +$3.34M +22,659 New
COPPSERS
525
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.19M +$18.7K +127 +0.6%

TMO Hedge Fund Activity: Q4 2016 in Review

1,113 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2016, worth a combined $48.7B — down 12% from $55.2B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 55 closed out — a net gain of 86 holders — while 388 added to existing stakes and 434 trimmed.

The largest buyer was Generation Investment Management, adding an estimated $246M. The largest seller was T. Rowe Price Associates, cutting an estimated $845M.

  • 1,113 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2016, up from 1,044 in Q3 2016.
  • Funds reported $48.7B of Thermo Fisher Scientific stock for Q4 2016, down 12% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q4 2016 and 55 closed out, a net change of +86 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2016 was Generation Investment Management, an estimated $246M added.
  • The largest Thermo Fisher Scientific seller in Q4 2016 was T. Rowe Price Associates, an estimated $845M sold.

Based on aggregated 13F filings for Q4 2016.